This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Dentin Sensitivity
and you are
The phase for this study is not defined.
Show me locations

The purpose

Aim: to investigate the clinical effectiveness over 12 weeks of three different biomaterials, nano-hydroxyapatite based, in the therapy of the dental sensitivity. Methods: The study is designed as a randomized clinical trial comparing: 1) Cavex Bite&White ExSense, 2) Teethmate™ Desensitizer , 3) Ghimas Dentin Desensitizer. The pain experience was generated by a cold stimulus directly to a sensitive tooth surface and assessed using the Visual Analogue Scale (VAS). The response was recorded before the application of the materials (PRE-1), immediately after (POST-1), at 1-week (POST-2), 4-weeks (POST-3) and 12-week controls (POST-4).

Provided treatments

  • Other: Cavex Bite&White ExSense
  • Other: Kuraray Teethmate™ Desensitizer
  • Other: Ghimas Dentin Desensitizer
Tris trial is registered with FDA with number: NCT02770573. The sponsor of the trial is Università degli Studi di Sassari and it is looking for 90 volunteers for the current phase.
Official trial title:
Long-term Response of Three Biomaterials Used as Desensitizer Agents Under Oral Environmental Exposure.